HSA GN-20GN-20
Guidance on Clinical Evaluation
SingaporeHealth Sciences AuthorityClinical Trials
What this code is
GN-20 is the official HSA identifier for “Guidance on Clinical Evaluation”. GN-20 is the official identifier HSA uses for this instrument.
- Instrument
- GN-20
- Full name
- GN-20
- Category
- Clinical Trials
Source links
- Authority source
- English
- Readable HTML
- 23 articles · 1 language version
Issuing-authority publication; confirm whether a later amendment or consolidated version applies.
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
- Published
- November 2022
- Effective
- —
Readable full text
Open a language version
Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
About this regulation
Guidance on Clinical Evaluation
HSA GN-20 Revision 2 (November 2022). Exact PDF from the official guidance-documents collection. Ingested as sec-1 through sec-7 plus Annexes 1–7.
GN-20 is the official identifier HSA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.